David Benito Laorga’s Haemophilia Team Hosts Hemosfera
David Benito Laorga, Business Unit Director and Management Team Member Novo Nordisk Spanish Affiliate, shared on LinkedIn:
”This weekend, our haemophilia team hosted Hemosfera, a truly innovative meeting centered on a new treatment with the potential to reduce treatment burden, improve quality of life, and open new possibilities for patients and families.
I’m especially proud of the team behind the scenes.
From concept to execution, this event was powered by strong ownership, deep commitment, and a shared conviction that meaningful innovation requires doing things differently—and doing them well.
This is what high-performing teams look like.
My sincere thanks as well to all the speakers for the depth and quality of the discussions.
Your insights and engagement were critical to making this a truly valuable and impactful event.
Proud of the team. Motivated by the impact we can create for patients.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026